Approval · Notice of Compliance 4677 · 1996
STREPTASE: Notice of Compliance 4677
Issued June 18, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4677
- Date
- June 18, 1996
- Company
- Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Fibrinolytic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STREPTASE | 02228130 | — |
| STREPTASE | 02228149 | — |
| STREPTASE | 02228122 | — |
Medicinal ingredients
- STREPTOKINASE 250,000 UNIT per VIAL
- STREPTOKINASE 750,000 UNIT per VIAL
- STREPTOKINASE 1,500,000 UNIT per VIAL